GM1 GANGLIOSIDOSIS TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snapshot, By Product Type
• Market Snapshot, By Disease Type
• Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Pipeline Analysis
• Regulatory Scenario
• Key Development
• Epidemiology
• Primary Research Insights
• Patient Insights
• Physician Insights
• Manufacturer Insights

4. Global GM1 Glangliosidosis Treatment Market, By Product Type, 2021-2033 (USD Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022–2033
• Segment Trends
• LYS-GM101
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
• PBGM01
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
• AXO-AAV-GM1
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)

5. Global GM1 Glangliosidosis Treatment Market, By Disease Type, 2021–2033 (USD Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2022–2033
• Segment Trends
• Type 1 GM1 Gangliosidosis
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
• Type 2 GM1 Gangliosidosis
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
• Type 3 GM1 Gangliosidosis
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)

6. Global GM1 Glangliosidosis Treatment Market, By Region, 2021–2033 (USD Mn)

• Introduction
• Market Share Analysis, By Country, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, For Countries, 2022–2033
• North America
• Introduction
• Market Size and Forecast, By Product Type, 2021–2033 (USD Mn)
• Market Size and Forecast, By Disease Type, 2021–2033 (USD Mn)
• Market Size and Forecast, By Country, 2021–2033 (USD Mn)
• U.S.
• Canada
• Europe
• Introduction
• Market Size and Forecast, By Product Type, 2021–2033 (USD Mn)
• Market Size and Forecast, By Disease Type, 2021–2033 (USD Mn)
• Market Size and Forecast, By Country, 2021–2033 (USD Mn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Latin America
• Introduction
• Market Size and Forecast, By Product Type, 2021–2033 (USD Mn)
• Market Size and Forecast, By Disease Type, 2021–2033 (USD Mn)
• Market Size and Forecast, By Country, 2021–2033 (USD Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Asia Pacific
• Introduction
• Market Size and Forecast, By Product Type, 2021–2033 (USD Mn)
• Market Size and Forecast, By Disease Type, 2021–2033 (USD Mn)
• Market Size and Forecast, By Country, 2021–2033 (USD Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• Introduction
• Market Size and Forecast, By Product Type, 2021–2033 (USD Mn)
• Market Size and Forecast, By Disease Type, 2021–2033 (USD Mn)
• Market Size and Forecast, By Country, 2021–2033 (USD Mn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• Introduction
• Market Size and Forecast, By Product Type, 2021–2033 (USD Mn)
• Market Size and Forecast, By Disease Type, 2021–2033 (USD Mn)
• Market Size and Forecast, By Country, 2021–2033 (USD Mn)
• Central Africa
• South Africa
• North Africa

7. Competitive Landscape

• Company Profiles
• Axovant Gene Therapies Ltd.
• Company Overview
• Clinical Trial Phase Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• Passage Bio
• Company Overview
• Clinical Trial Phase Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• Lysogene
• Company Overview
• Clinical Trial Phase Portfolio
• Financial Overview
• Key Highlights
• Market Strategies

*Browse 16 market data tables and 16 figures on “GM1 Glangliosidosis Treatment Market– Global forecast to 2033”.